Correlation
The correlation between TMDX and DXCM is 0.46, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
TMDX vs. DXCM
Compare and contrast key facts about TransMedics Group, Inc. (TMDX) and DexCom, Inc. (DXCM).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: TMDX or DXCM.
Performance
TMDX vs. DXCM - Performance Comparison
Loading data...
Key characteristics
TMDX:
-0.10
DXCM:
-0.48
TMDX:
0.26
DXCM:
-0.39
TMDX:
1.04
DXCM:
0.93
TMDX:
-0.16
DXCM:
-0.52
TMDX:
-0.25
DXCM:
-0.86
TMDX:
43.39%
DXCM:
37.95%
TMDX:
69.15%
DXCM:
58.62%
TMDX:
-73.69%
DXCM:
-94.61%
TMDX:
-27.82%
DXCM:
-47.30%
Fundamentals
TMDX:
$4.33B
DXCM:
$33.64B
TMDX:
$1.41
DXCM:
$1.35
TMDX:
90.16
DXCM:
63.56
TMDX:
8.86
DXCM:
8.11
TMDX:
16.22
DXCM:
14.68
TMDX:
$488.23M
DXCM:
$4.15B
TMDX:
$290.25M
DXCM:
$2.46B
TMDX:
$82.66M
DXCM:
$889.80M
Returns By Period
In the year-to-date period, TMDX achieves a 103.88% return, which is significantly higher than DXCM's 10.33% return.
TMDX
103.88%
40.54%
46.60%
-6.80%
63.34%
57.28%
N/A
DXCM
10.33%
22.12%
10.01%
-27.76%
4.83%
-1.93%
16.81%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
TMDX vs. DXCM — Risk-Adjusted Performance Rank
TMDX
DXCM
TMDX vs. DXCM - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for TransMedics Group, Inc. (TMDX) and DexCom, Inc. (DXCM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
TMDX vs. DXCM - Dividend Comparison
Neither TMDX nor DXCM has paid dividends to shareholders.
Drawdowns
TMDX vs. DXCM - Drawdown Comparison
The maximum TMDX drawdown since its inception was -73.69%, smaller than the maximum DXCM drawdown of -94.61%. Use the drawdown chart below to compare losses from any high point for TMDX and DXCM.
Loading data...
Volatility
TMDX vs. DXCM - Volatility Comparison
TransMedics Group, Inc. (TMDX) has a higher volatility of 19.77% compared to DexCom, Inc. (DXCM) at 16.55%. This indicates that TMDX's price experiences larger fluctuations and is considered to be riskier than DXCM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
TMDX vs. DXCM - Financials Comparison
This section allows you to compare key financial metrics between TransMedics Group, Inc. and DexCom, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TMDX vs. DXCM - Profitability Comparison
TMDX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, TransMedics Group, Inc. reported a gross profit of 88.23M and revenue of 143.54M. Therefore, the gross margin over that period was 61.5%.
DXCM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, DexCom, Inc. reported a gross profit of 589.00M and revenue of 1.04B. Therefore, the gross margin over that period was 56.9%.
TMDX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, TransMedics Group, Inc. reported an operating income of 27.44M and revenue of 143.54M, resulting in an operating margin of 19.1%.
DXCM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, DexCom, Inc. reported an operating income of 133.70M and revenue of 1.04B, resulting in an operating margin of 12.9%.
TMDX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, TransMedics Group, Inc. reported a net income of 25.68M and revenue of 143.54M, resulting in a net margin of 17.9%.
DXCM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, DexCom, Inc. reported a net income of 105.40M and revenue of 1.04B, resulting in a net margin of 10.2%.